
Copyright © 2025 KAP
Central Securities Depository & Trade Repository of Türkiye
[CONSOLIDATION_METHOD_TITLE] | [CONSOLIDATION_METHOD] |
İlgili Şirketler Related Companies | [] | ||||||||
İlgili Fonlar Related Funds | [] | ||||||||
Türkçe Turkish | İngilizce English | ||||||||
oda_MaterialEventDisclosureGeneralAbstract| |
| ||||||||
oda_UpdateAnnouncementFlag| |
| Hayır (No) | Hayır (No) | ||||||
oda_CorrectionAnnouncementFlag| |
| Hayır (No) | Hayır (No) | ||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject| |
| - | |||||||
oda_DelayedAnnouncementFlag| |
| Hayır (No) | Hayır (No) | ||||||
oda_AnnouncementContentSection| |
| ||||||||
oda_ExplanationSection| |
| ||||||||
oda_ExplanationTextBlock| | Şirketimizin Türk Patent ve Marka Kurumu nezdinde tescilini talep etmiş olduğu, 2023/130176 Capoeria zirai ilaç markası, 03.10.2023 tarihinden itibaren 10 yıl süreyle korunmak üzere 16.01.2024 tarihinde; 2023/130174 Mitropan zirai ilaç markası ise 03.10.2023 tarihinden itibaren 10 yıl süreyle korunmak üzere, 17.01.2024 tarihinde tescil edilmiştir: Kamuoyuna saygı ile duyurulur. |
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.